Overall Technical outlook

Price Summary

On 2025-08-14, JBCHEPHARM's stock opened at 1725.0, reached a peak of 1729.0, dropped to 1701.4, and ended -0.48% lower at 1716.7, with a volume of 74203 shares.
The stock's peak price over the last 52 weeks is 1970.6, with the lowest being 1504.4.
Future price predictions suggest a range between 1752.0 and 2458.0, with an average expected price of 2019.0834, as per 12 analysts.

Technicals

Support and Resistance: The price of 1716.7 is supported at 1658.7 and capped by resistance at 1730.4. These levels mark key points for J. B. Chemicals & Pharmaceuticals Limited where the price could find stability, with 1658.7 as a floor and 1730.4 as a ceiling.
JBCHEPHARM supportResistance 0ad99e
Support/Resistance for JBCHEPHARM


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
JBCHEPHARM aroon 0ad99e
Aroon chart for J. B. Chemicals & Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
JBCHEPHARM bbands 0ad99e
Bolinger Bands chart for J. B. Chemicals & Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bearish, establishing a resistance level that could cap any potential upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for JBCHEPHARM.
JBCHEPHARM psar 0ad99e
Parabolic Stop and Reverse chart for J. B. Chemicals & Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
JBCHEPHARM stoch 0ad99e
Stochastic chart for J. B. Chemicals & Pharmaceuticals Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are aligned in a bearish pattern, signaling a downtrend. However, the slopes of the 20 and 50 SMAs are starting to waver, suggesting that the bearish momentum may be weakening. This could be an early sign of a potential bullish reversal for JBCHEPHARM, as the market's downward trajectory begins to lose strength and a possible shift towards more positive price action may occur soon.
JBCHEPHARM trippleSMA 0ad99e
Tripple SMA chart for J. B. Chemicals & Pharmaceuticals Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.